KRAS and gonorrhea: In the first study, [96] the detection rates of mutant KRAS in pancreatic tissue were 91% in PDAC, 71% in periampullary carcinoma (PAC) and 67% in CP, and in fecal samples, 40% in PDAC, 33% in CP and 0% in PAC.